144 related articles for article (PubMed ID: 28060514)
1. Targeted Covalent Inhibition of Grb2-Sos1 Interaction through Proximity-Induced Conjugation in Breast Cancer Cells.
Yu Y; Nie Y; Feng Q; Qu J; Wang R; Bian L; Xia J
Mol Pharm; 2017 May; 14(5):1548-1557. PubMed ID: 28060514
[TBL] [Abstract][Full Text] [Related]
2. SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1.
Qu Y; Chen Q; Lai X; Zhu C; Chen C; Zhao X; Deng R; Xu M; Yuan H; Wang Y; Yu J; Huang J
Mol Cancer; 2014 Apr; 13():95. PubMed ID: 24775912
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
McDonald CB; Seldeen KL; Deegan BJ; Farooq A
Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
[TBL] [Abstract][Full Text] [Related]
4. Molecular Dynamics model of peptide-protein conjugation: case study of covalent complex between Sos1 peptide and N-terminal SH3 domain from Grb2.
Luzik DA; Rogacheva ON; Izmailov SA; Indeykina MI; Kononikhin AS; Skrynnikov NR
Sci Rep; 2019 Dec; 9(1):20219. PubMed ID: 31882608
[TBL] [Abstract][Full Text] [Related]
5. Quantifying intramolecular binding in multivalent interactions: a structure-based synergistic study on Grb2-Sos1 complex.
Sethi A; Goldstein B; Gnanakaran S
PLoS Comput Biol; 2011 Oct; 7(10):e1002192. PubMed ID: 22022247
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of Grb2-Sos1 interaction: the N-terminal SH3 domain of Grb2 mediates affinity.
Sastry L; Lin W; Wong WT; Di Fiore PP; Scoppa CA; King CR
Oncogene; 1995 Sep; 11(6):1107-12. PubMed ID: 7566970
[TBL] [Abstract][Full Text] [Related]
7. High-Affinity Interactions of the nSH3/cSH3 Domains of Grb2 with the C-Terminal Proline-Rich Domain of SOS1.
Liao TJ; Jang H; Nussinov R; Fushman D
J Am Chem Soc; 2020 Feb; 142(7):3401-3411. PubMed ID: 31970984
[TBL] [Abstract][Full Text] [Related]
8. The intramolecular allostery of GRB2 governing its interaction with SOS1 is modulated by phosphotyrosine ligands.
Kazemein Jasemi NS; Herrmann C; Magdalena Estirado E; Gremer L; Willbold D; Brunsveld L; Dvorsky R; Ahmadian MR
Biochem J; 2021 Jul; 478(14):2793-2809. PubMed ID: 34232285
[TBL] [Abstract][Full Text] [Related]
9. The isoform-specific stretch of hSos1 defines a new Grb2-binding domain.
Zarich N; Oliva JL; Jorge R; Santos E; Rojas JM
Oncogene; 2000 Nov; 19(51):5872-83. PubMed ID: 11127818
[TBL] [Abstract][Full Text] [Related]
10. Regions outside of conserved PxxPxR motifs drive the high affinity interaction of GRB2 with SH3 domain ligands.
Bartelt RR; Light J; Vacaflores A; Butcher A; Pandian M; Nash P; Houtman JC
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2560-9. PubMed ID: 26079855
[TBL] [Abstract][Full Text] [Related]
11. Sos-mediated activation of rac1 by p66shc.
Khanday FA; Santhanam L; Kasuno K; Yamamori T; Naqvi A; Dericco J; Bugayenko A; Mattagajasingh I; Disanza A; Scita G; Irani K
J Cell Biol; 2006 Mar; 172(6):817-22. PubMed ID: 16520382
[TBL] [Abstract][Full Text] [Related]
12. SH3 domains of Grb2 adaptor bind to PXpsiPXR motifs within the Sos1 nucleotide exchange factor in a discriminate manner.
McDonald CB; Seldeen KL; Deegan BJ; Farooq A
Biochemistry; 2009 May; 48(19):4074-85. PubMed ID: 19323566
[TBL] [Abstract][Full Text] [Related]
13. UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug.
Oneyama C; Nakano H; Sharma SV
Oncogene; 2002 Mar; 21(13):2037-50. PubMed ID: 11960376
[TBL] [Abstract][Full Text] [Related]
14. Oligomerization of signaling complexes by the multipoint binding of GRB2 to both LAT and SOS1.
Houtman JC; Yamaguchi H; Barda-Saad M; Braiman A; Bowden B; Appella E; Schuck P; Samelson LE
Nat Struct Mol Biol; 2006 Sep; 13(9):798-805. PubMed ID: 16906159
[TBL] [Abstract][Full Text] [Related]
15. Interaction domains of Sos1/Grb2 are finely tuned for cooperative control of embryonic stem cell fate.
Findlay GM; Smith MJ; Lanner F; Hsiung MS; Gish GD; Petsalaki E; Cockburn K; Kaneko T; Huang H; Bagshaw RD; Ketela T; Tucholska M; Taylor L; Bowtell DD; Moffat J; Ikura M; Li SS; Sidhu SS; Rossant J; Pawson T
Cell; 2013 Feb; 152(5):1008-20. PubMed ID: 23452850
[TBL] [Abstract][Full Text] [Related]
16. Small Molecule-Mediated Activation of RAS Elicits Biphasic Modulation of Phospho-ERK Levels that Are Regulated through Negative Feedback on SOS1.
Howes JE; Akan DT; Burns MC; Rossanese OW; Waterson AG; Fesik SW
Mol Cancer Ther; 2018 May; 17(5):1051-1060. PubMed ID: 29440291
[TBL] [Abstract][Full Text] [Related]
17. Grb2 is a negative modulator of the intrinsic Ras-GEF activity of hSos1.
Zarich N; Oliva JL; Martínez N; Jorge R; Ballester A; Gutiérrez-Eisman S; García-Vargas S; Rojas JM
Mol Biol Cell; 2006 Aug; 17(8):3591-7. PubMed ID: 16760435
[TBL] [Abstract][Full Text] [Related]
18. Mutant huntingtin replaces Gab1 and interacts with C-terminal SH3 domain of growth factor receptor binding protein 2 (Grb2).
Baksi S; Basu S; Mukhopadhyay D
Neurosci Res; 2014 Oct; 87():77-83. PubMed ID: 25041730
[TBL] [Abstract][Full Text] [Related]
19. The ability of Sos1 to oligomerize the adaptor protein LAT is separable from its guanine nucleotide exchange activity in vivo.
Kortum RL; Balagopalan L; Alexander CP; Garcia J; Pinski JM; Merrill RK; Nguyen PH; Li W; Agarwal I; Akpan IO; Sommers CL; Samelson LE
Sci Signal; 2013 Nov; 6(301):ra99. PubMed ID: 24222714
[TBL] [Abstract][Full Text] [Related]
20. Type II cGMP-dependent protein kinase inhibits EGF-induced MAPK/JNK signal transduction in breast cancer cells.
Lan T; Chen Y; Sang J; Wu Y; Wang Y; Jiang L; Tao Y
Oncol Rep; 2012 Jun; 27(6):2039-44. PubMed ID: 22427012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
